Calcific aorticvalvestenosis is the result of regulated cell processes.
2
Alkaptonuric ochronosis is a rare cause of aorticvalvestenosis.
3
Arterial hypertension and aorticvalvestenosis are common disorders and frequently present as concomitant diseases, especially in elderly patients.
4
Asymptomatic athletes with moderate aorticvalvestenosis should only take part in sports with low dynamic and static stress.
5
Increase in left ventricular (LV) mass develops as a compensatory mechanism against pressure overload in aorticvalvestenosis.
6
The case of a 2-year-old infant admitted to our Institution with a diagnosis of severe aorticvalvestenosis is presented.
7
Background: Rapid deployment bioprostheses (RDBs) have been recently introduced into clinical practice for the treatment of severe aorticvalvestenosis.
8
Results: Eleven patients underwent transcatheter aortic valve replacement for severe symptomatic aorticvalvestenosis and one patient for severe aortic valve regurgitation.
9
Although she had no overt symptoms, she had severe aorticvalvestenosis with a transvalvular pressure gradient of more than 150 mmHg.
10
Background: The management of uncomplicated aorticvalvestenosis presenting with critical obstruction in infants continues to be associated with significant morbidity and mortality.
11
Calcific aorticvalvestenosis, the most frequent heart valve disorder in developed countries, is an actively regulated process with similarities to bone formation.
12
Calcific aorticvalvestenosis is the commonest form of heart valve disease in high-income countries and set to become a major health care burden.
13
Background: BAV is a valuable therapeutic tool for patients with symptomatic severe aorticvalvestenosis (AS) at prohibitive risk for TAVI or surgery.
14
It was the aim of this study to assess the usefulness of TDI in patients with moderate to severe aorticvalvestenosis (AS).
15
Background: Transcatheter aortic valve implantation (TAVI) has been proposed as a therapeutic option for high-risk or inoperable patients with severe symptomatic aorticvalvestenosis.
16
Introduction: Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients with underlying sever aorticvalvestenosis across all spectrum of the disease.